Drug Discovery & Biology · first seen 05 November 2026, 01:37 UTC
MindWalk signs multi-year AI drug discovery deal with Teva Australia
MindWalk (NASDAQ:HYFT) signed a multi-year agreement with Teva Australia covering its AI drug discovery platform, Kalkine reports.
MindWalk
- Domain
- other
Read it at Kalkine →
Coverage: 1 sources, in order
-
Kalkine Read the article →
← Front page